Clinical outcomes of endoscopic submucosal dissection for superficial Barrett's adenocarcinoma

Gastrointest Endosc. 2014 Aug;80(2):239-45. doi: 10.1016/j.gie.2014.01.022. Epub 2014 Feb 22.


Background: Advances in diagnostic techniques have allowed early stage detection of superficial Barrett's adenocarcinoma (SBA) as well as resection by endoscopic submucosal dissection (ESD). Few reports exist, however, on the safety and efficacy of ESD for SBA.

Objective: To analyze outcomes of ESD for SBA in relation to clinicopathological features of the lesions.

Design: Retrospective study.

Setting: University hospital.

Patients: Twenty-three patients (21 men, 2 women; mean age, 63 years) with 26 SBAs.

Intervention esd main outcome measurements: We examined outcomes of ESD in relation to the clinicopathological features of SBAs. The main outcomes assessed were en bloc resection rate, operation time, adverse event rates, additional resection rate, and time between ESD and any recurrence.

Results: Twenty lesions (87%) derived from short-segment Barrett's esophagus, and 3 lesions (13%) derived from long-segment Barrett's esophagus. The majority of SBAs (54%) were located in the 0 to 3 o'clock circumferential quadrant. Median tumor size was 15 mm (range 5-60 mm). Macroscopic types were flat elevated (n = 13, 50%), depressed (n = 12, 46%), and protruded (n = 1, 4%). The SBAs appeared red (n = 23, 88%) or normally pale (n = 3, 12%). Under magnifying narrow-band imaging, all SBAs showed an irregular mucosal pattern and an irregular vascular pattern. The endoscopic en bloc resection rate was 100% (26/26), and the pathological en bloc resection rate was 85% (22/26). The median procedure time was 95 minutes (range, 30-210 minutes). Delayed bleeding occurred in 1 case, but there was no perforation. The SBAs were of the differentiated type (n = 25, 96%) or poorly differentiated type (n = 1, 4%). The tumor had invaded the superficial muscularis mucosa (n = 3, 12%), lamina propria mucosa (n = 5, 19%, deep muscularis mucosa (n = 9, 34%), SM1 (n = 3, 12%), and SM2 (n = 6, 23%). Additional surgical resection after ESD was performed in 9 cases, and there were no residual tumors, but 1 lymph node metastasis was found. There were no recurrent tumors; however, 1 metachronous adenocarcinoma was diagnosed 42 months after ESD.

Limitations: Single-center, retrospective study.

Conclusions: ESD appears to be a safe and effective treatment strategy for early stage SBA.

MeSH terms

  • Adenocarcinoma / secondary
  • Adenocarcinoma / surgery*
  • Aged
  • Aged, 80 and over
  • Barrett Esophagus / pathology
  • Dissection* / adverse effects
  • Esophageal Neoplasms / pathology*
  • Esophageal Neoplasms / surgery*
  • Esophagoscopy* / adverse effects
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mucous Membrane / surgery
  • Narrow Band Imaging
  • Neoplasm Invasiveness
  • Neoplasm, Residual
  • Operative Time
  • Retrospective Studies